Stable colloidal chitosan/alginate nanocomplexes: Fabrication, formulation optimization and repaglinide loading

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 6, Issue 2, 2014, Pages 520-525

  Elmowafy, Enas ^a   Osman, Rihab ^a   El Shamy, Abd El Hameed A ^a   Awad, Gehanne As ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Alginate; Chitosan; Ionic gelation; Nanocomplexes; Repaglinide

Indexed keywords

ALGINIC ACID; CHITOSAN; DEXTRAN SULFATE; NANOPARTICLE; POLYMER; REPAGLINIDE;

ARTICLE; COLLOID; CONCENTRATION PROCESS; CROSS LINKING; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; ENCAPSULATION; INFRARED SPECTROSCOPY; LIGHT SCATTERING; NANOCOMPLEX; PARTICLE SIZE; PH MEASUREMENT; STATIC ELECTRICITY; THERMAL ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 84897146750     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Goycoolea FM, Lollo G, Lopez C, Quaglia F, Alonso MJ. Chitosan-Alginate Blended Nano particles as Carriers for the Transmucosal Delivery of Macro molecules. Bio-macro molecules 2009; 10(7): 1736-1743.
2. Meng X, Tian F, Yang J, He C, Xing N, Li F. Chitosan and alginate polyelectrolyte complex membranes and their properties for wound dressing application. J Mater Sci Mater Med 2010; 21: 1751-1759.
3. Fiebrig I, Harding SE, Davis SS. Sedimentation analysis of potential interaction between mucins and a putative bioadhesive polymer. Progr Coll Polym Sci 1994; 94: 66-73.
4. Smith JM, Dornish M, Wood, EJ. Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption. Biomaterials 2005; 26(16): 3269-3276.
5. Chae SY, Jang MK, Nah JW. Influence of molecular weight on oral absorption of water soluble chitosans. J Control Release 2005; 102: 383-394.
6. Papadimitriou S, Bikiaris D, Avgoustakis K, Karavas E, Georgarakis M. Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbo Poly 2008; 73(1): 44-54.
7. Gubbala SK. Polyelectrolyte complex: A pharmaceutical review. Int J Pharm Biol Sci 2012; 2(3): 399-407.
8. Soane RJ, Ferier M, Perkins AC, Jones NS, Davis SS, Illum L. Evaluation of the clearance characteristics of bioadhesive system in humans. Int J Pharm 1999; 178: 55-65.
9. Brooking J, Davis SS, Illum L. Transport of nanoparticles across the rat nasal mucosa. J Drug Target. 2001; 9: 267-279.
10. United States Patent, Sung H-W, Liang H-F, Tu H. Nanoparticles for paracellular drug delivery, Patent No 7, 265, 090 2007.
11. Yue Z-G, Wei W, Lv P-P, Yue H, Wang L-Y, Su, Z-G, Ma G-H. Surface Charge Affects Cellular Uptake and Intracellular Trafficking of Chitosan-Based Nanoparticles. Biomacromolecules 2011; 12(7): 2440-2446.
12. Grell W, Hurnaus R, Griss G. Repaglinide and related hypoglycemic benzoic acid derivatives. J Med Chem. 1998; 41: 5219-5246.
13. Makino C, Sakai H, Yabuki A. Nateglinide controlled release tablet containing compressionable enteric coated granules. Chem Pharm Bull 2010; 58(9): 1136-1141.
14. Lund SS, Tarnow L, Stehouwer CDA, Schalkwijk CG, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag A. Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial. Diabetes Obes Metab 2007; 9(3): 394-407.
15. Jain S, Saraf S. Repaglinide-loaded long-circulating biodegradable nanoparticles: Rational approach for the management of type 2 diabetes mellitus. J Diabetes 2009; 1(1): 29-35.
16. Fan W, Yan W, Xu Z, Ni H. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloids Surf B Biointerfaces 2012; 90: 21-27.
17. Simsek-Ege FA, Bond GM, Stringer J. Polyelectrolye Complex Formation Between Alginate and Chitosan as a Function of pH. J Appl Polym Sci 2003; 88: 346-351.
18. Ribeiro AJ, Silva C, Ferreira D, Veiga F. Chitosan reinforced alginate microspheres obtained through the emulsification/internal gelation technique. Eur J Pharma Sci 2005; 25(1): 31-40.
19. Katas H, Raja MA, Lam KL. Development of chitosan nanoparticles as a stable drug delivery system for protein/siRNA. Int J Biomat 2013; 1-9.
20. Mahmoud AA, El-Feky GS, Kamel R, Awad GEA. Chitosan/sulfobutylether-B-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Int J Pharm 2011; 413: 229-236.
21. Aramǎ C, Nicolescu C, Nedelcu A, Monciu C-M. Synthesis and characterization of the inclusion complex between repaglinide and sulfobutylether-β-cyclodextrin (Captisol®). J Inc Phenom and Macrocyclic Chem 2011; 70(3-4): 421-428.
22. Ventura CA, Tommasini S., Crupi E, Giannone I, Cardile V, Musumeci T, Puglisi G. Chitosan microspheres for intrapulmonary administration of moxifloxacin: Interaction with biomembrane models and in vitro permeation studies. Eur. J. Pharm. Biopharm. 2008; 68: 235-244.
23. Shabbeer S, Shaheeda, & Ramanamurthy, KV. Formulation and evaluation of chitosan sodium alginate microcapsules of 5-fluorouracil for colorecal cancer. Int J Res Pharm Chem 2012; 2(1): 7-19.
24. Yoksan R, Jirawutthiwongchai J, Arpo K. Encapsulation of ascorbyl palmitate in chitosan nanoparticles by oil-in-water emulsion and ionic gelation processes. Colloids Surf B Biointerfaces 2010; 76: 292-297.
25. Qi L, Xu Z, Jiang X, Hu C, Zou X. Preparation and antibacterial activity of chitosan nanoparticles. Carbohyd Res 2004; 339: 2693-2700.
26. Li P, Dai Y, Zhang J, Wang A, Wei Q. Chitosan-Alginate nanoparticles as a novel drug delivery system for nifedipine. Int J Biomed Sci 2008; 4(3): 221-228.
27. Morris GA, Castile J, Smith A, Adams GG, Harding SE. The effect of prolonged storage at different temperatures on the particle size distribution of tripolyphosphate (TPP)-chitosan nanoparticles. Carbohyd Polym 2011; 84: 1430-1434.